Concepedia

Efficacy and Safety of Rituximab Treatment in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitides: Results from a German Registry (GRAID)

Petra Roll, Eva Ostermeier, Marion Haubitz, Svjetlana Lovric, L. Unger, Julia U. Holle, Ina Kötter, Jörg Henes, Raoul Bergner, Andrea Rubbert‐Roth,

The Journal of Rheumatology · 2012 · 37 citations · 12 references

DOIFull text

Open access

Abstract

RTX was well tolerated with good clinical efficacy in patients with refractory AAV.

References

12

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

John H. Stone, Peter A. Merkel, Robert Spiera et al. · New England Journal of Medicine · 2010 · 2.7K citations · Full text

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

Rachel Jones, Jan Willem Cohen Tervaert, Thomas Häuser et al. · New England Journal of Medicine · 2010 · 1.7K citations · Full text

Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody–associated vasculitis

Karina A. Keogh, Mark E. Wylam, John H. Stone et al. · Arthritis & Rheumatism · 2005 · 449 citations

Rituximab for Refractory Wegener's Granulomatosis

Karina A. Keogh, Steven R. Ytterberg, Fernando C. Fervenza et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 400 citations · Full text

Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

Ulrich Specks, Fernando C. Fervenza, Thomas J. McDonald et al. · Arthritis & Rheumatism · 2001 · 358 citations · Full text

, , +18